Emerald Mutual Fund Advisers Trust’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-172,141
Closed -$3.37M 238
2024
Q1
$3.37M Sell
172,141
-640,214
-79% -$13.5M 0.18% 114
2023
Q4
$18.7M Buy
812,355
+70,224
+9% +$1.57M 0.99% 38
2023
Q3
$17.1M Buy
742,131
+16,976
+2% +$432K 1.03% 33
2023
Q2
$18.9M Buy
725,155
+22,975
+3% +$607K 1.03% 38
2023
Q1
$19.4M Buy
702,180
+49,400
+8% +$1.3M 1.15% 28
2022
Q4
$14.8M Buy
652,780
+352,405
+117% +$9.81M 0.92% 47
2022
Q3
$10.2M Buy
+300,375
New +$11.1M 0.65% 65
2021
Q4
Sell
-113,584
Closed -$2.68M 230
2021
Q3
$2.68M Sell
113,584
-84,216
-43% -$2.94M 0.09% 151
2021
Q2
$8.78M Buy
+197,800
New +$7.3M 0.29% 111

Other funds holding PRVA

Emerald Mutual Fund Advisers Trust's PRVA Position: Q2 2024 in Review

Emerald Mutual Fund Advisers Trust sold out of Privia Health (PRVA) in Q2 2024, closing a stake of 172,141 shares — an estimated $3.37M sold.

Emerald Mutual Fund Advisers Trust first reported a position in PRVA in Q2 2021 and held it in 9 quarters. The position peaked at $19.4M in Q1 2023. 225 funds tracked by Wall St. Rank hold PRVA as of Q2 2024.

  • Emerald Mutual Fund Advisers Trust reported no remaining Privia Health position as of Q2 2024 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 172,141 Privia Health shares in Q2 2024, an estimated $3.37M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Privia Health in Q2 2021 and held it in 9 quarters.
  • Emerald Mutual Fund Advisers Trust's Privia Health position peaked at $19.4M in Q1 2023.
  • 225 funds tracked by Wall St. Rank held Privia Health as of Q2 2024.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2024, filed 6 Aug 2024.